Vascular Closure Device Market Report
First published: 21 October 2024 | Last updated: 28 May 2026 | Report Code: vascular-closure-device
Vascular Closure Device Market — USD 3.5 billion in 2023, Growing to USD 7.15B by 2033 at 7.2% CAGR
This report provides a comprehensive analysis of the Vascular Closure Device market, covering market trends, forecasts from 2023 to 2033, industry dynamics, and segmentation insights. It aims to equip stakeholders with relevant data and insights to navigate the evolving landscape of this medical device market.
Key Takeaways
- Global market expands from $3.50 Billion in 2023 to $7.15 Billion in 2033 at a 7.2% CAGR.
- Europe is largest regional market; Middle East and Africa is regional market region based on implied CAGR across 2023 to 2033.
- Middle East and Africa is identified as the regional market region, increasing from $0.26 Billion to $0.54 Billion.
- North America grows from $1.13 Billion in 2023 to $2.31 Billion in 2033, showing sustained demand.
- Key vendors include Abbott Laboratories, Terumo Corporation, Medtronic, and Boston Scientific Corporation.
Vascular Closure Device Market Report — Executive Summary
Regional analysis shows Europe as largest market and Middle East and Africa as fastest-growing region by implied CAGR. The Vascular Closure Device market is projected to more than double between 2023 and 2033, with the global market moving from $3.50 Billion to $7.15 Billion at a 7.2% CAGR over the forecast period 2023 to 2033. Growth is being supported by rising preference for minimally invasive cardiovascular procedures, ongoing device innovation, and greater adoption across hospitals and ambulatory surgical centers. Regionally, Europe holds the largest share while Middle East and Africa exhibits the highest implied growth rate. Market structure includes device-type segmentation (mechanical and active closure devices), design types (single-use and reusable), and applications spanning diagnostic and therapeutic procedures. Major vendors such as Abbott Laboratories, Terumo Corporation, Medtronic, and Boston Scientific Corporation are prominent in the competitive landscape. The market outlook reflects continued investment in product development and efficiency improvements to meet procedural and patient recovery needs.
Key Growth Drivers
- Wider adoption of minimally invasive cardiovascular procedures increasing demand for reliable closure solutions.
- Technological improvements in device designs enhancing hemostasis and procedural efficiency.
- Expanding hospital and ambulatory surgical center utilization supporting higher procedure volumes.
- Rising focus on patient recovery and reduced complication rates encouraging device uptake.
- Ongoing R&D and product launches by leading manufacturers driving differentiated offerings.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $3.50 Billion |
| CAGR (2023-2033) | 7.2% |
| 2033 Market Size | $7.15 Billion |
| Top Companies | Abbott Laboratories, Terumo Corporation, Medtronic , Boston Scientific Corporation |
| Published Date | 21 October 2024 |
| Last Modified Date | 28 May 2026 |
Vascular Closure Device Market Overview
Customize Vascular Closure Device Market Report market research report
- ✔ Get in-depth analysis of Vascular Closure Device market size, growth, and forecasts.
- ✔ Understand Vascular Closure Device's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Vascular Closure Device
What is the Market Size & CAGR of Vascular Closure Device Market Report market in 2023?
Vascular Closure Device Industry Analysis
Vascular Closure Device Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Vascular Closure Device Market Report Market Analysis Report by Region
Europe Vascular Closure Device Market Report:
Europe is largest regional market, rising from $1.2 Billion in 2023 to $2.44 Billion in 2033. 2 Billion in 2023 to $2.44 Billion in 2033 and is identified as the largest regional market. Demand is driven by wide uptake of minimally invasive interventions, established healthcare infrastructure, and continued introduction of improved vascular closure technologies.Asia Pacific Vascular Closure Device Market Report:
Asia Pacific grows from $0.65 Billion in 2023 to $1.33 Billion in 2033. Growth reflects rising access to minimally invasive procedures, expanding hospital capacity, and efforts to adopt newer closure devices that improve procedural efficiency and patient recovery.North America Vascular Closure Device Market Report:
North America grows from $1.13 Billion in 2023 to $2.31 Billion in 2033. Regional momentum reflects high procedure volumes in hospitals and ambulatory surgical centers, sustained adoption of advanced closure devices, and ongoing investment in device innovation and clinical best practices.South America Vascular Closure Device Market Report:
Latin America grows from $0.26 Billion in 2023 to $0.52 Billion in 2033. Regional expansion is supported by increased procedural volumes and gradual adoption of advanced device types in hospitals and surgical centers seeking better hemostasis solutions.Middle East & Africa Vascular Closure Device Market Report:
Middle East and Africa is fastest-growing region by implied CAGR, increasing from $0.26 Billion in 2023 to $0.54 Billion in 2033. 26 Billion in 2023 to $0.54 Billion in 2033 and is noted as the regional growth market at an implied 7.58% CAGR. Market growth is underpinned by expanding healthcare services, higher uptake of minimally invasive procedures, and growing procurement of vascular closure technologies.Tell us your focus area and get a customized research report.
Research Methodology
Vascular Closure Device Market Analysis By Device Type
The market is primarily comprised of mechanical devices and active closure devices. Mechanical devices account for approximately 80.84% of the market share as of 2023, with a projected market size growth from USD 2.83 billion to USD 5.78 billion by 2033. Active closure devices, while lesser in size, are crucial due to their specialized applications and growing adoption among healthcare providers.
Vascular Closure Device Market Analysis By Application
The application segment primarily divides into diagnostic and therapeutic procedures, with diagnostic procedures holding an 80.84% market share in 2023, growing to USD 5.78 billion by 2033, reflecting the increasing need for diagnostic interventions in the healthcare segment.
Vascular Closure Device Market Analysis By End User
Hospitals dominate the end-user segment with a share of 67.21%, reflecting the high volume of procedures performed within hospital settings. This segment is expected to grow from USD 2.35 billion in 2023 to USD 4.81 billion by 2033.
Vascular Closure Device Market Analysis By Design Type
The design type segment includes single-use devices and reusable devices. Single-use devices represent approximately 80.84% market share in 2023 with forecasts illustrating substantial growth reflecting preference trends towards hygiene and safety during surgical procedures.
Vascular Closure Device Market Analysis By Region
The regional analysis highlights varying growth rates, with North America leading the market share due to high healthcare investments, followed by Europe and Asia Pacific, showcasing significant expansion potential fueled by healthcare reforms and innovations.
Vascular Closure Device Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Vascular Closure Device Industry
Abbott Laboratories:
A global leader in healthcare, Abbott provides a wide range of Vascular Closure Devices and is known for its innovative approach in cardiovascular healthcare solutions.Terumo Corporation:
Terumo is a prominent player in vascular access and related devices, emphasizing quality and innovation in developing their Vascular Closure Devices.Medtronic :
Medtronic is a leading medical technology company that develops a variety of Vascular Closure Devices, focusing on enhancing procedural safety and efficiency.Boston Scientific Corporation:
Boston Scientific specializes in less invasive technologies, providing various Vascular Closure Devices aimed at improving patient care and outcomes.We're grateful to work with incredible clients.
FAQs
What is the market size of the Vascular Closure Device market in 2023?
The market size in 2023 is $3.50 Billion, as reported for the starting year of the forecast period.
How big will the Vascular Closure Device market be in 2033?
By 2033 the market is projected to reach $7.15 Billion according to the provided forecast figures.
What is CAGR for the Vascular Closure Device market?
The compound annual growth rate for the forecast period 2023 to 2033 is 7.2% as stated in the report data.
Which region is the fastest Growing in the Vascular Closure Device Market Report market?
Middle East and Africa is the fastest-growing region, projected to expand from $0.26 Billion in 2023 to $0.54 Billion in 2033, reflecting an implied 7.58% CAGR over the forecast period.
Which region is fastest Growing?
Middle East and Africa is identified as the regional market region, rising from $0.26 Billion in 2023 to $0.54 Billion in 2033.
Who are the top companies in the market?
Reported leading companies include Abbott Laboratories, Terumo Corporation, Medtronic, and Boston Scientific Corporation.
What are the main device Type segments?
Device-type segmentation includes Mechanical Devices and Active Closure Devices as specified in the supplied segment facts.
Which end Users are covered in the segmentation?
End-user categories listed are Hospitals, Ambulatory Surgical Centers, and Other End Users in the provided segment data.
What applications are included in the market?
Applications covered are Diagnostic Procedures and Therapeutic Procedures, according to the input segmentation.
How are design types classified?
Design types are categorized as Single Use Devices and Reusable Devices per the segment facts supplied.